Trabeculectomy less effective in UG versus POAG

Article

Trabeculectomy with mitomycin C is less effective in maintaining reductions in IOP in eyes with uveitic glaucoma (UG) compared with eyes with primary open-angle glaucoma (POAG), according to a recent study.

Trabeculectomy with mitomycin C is less effective in maintaining reductions in IOP in eyes with uveitic glaucoma (UG) compared with eyes with primary open-angle glaucoma (POAG), according to a study published in the Journal of Glaucoma. In addition, these researchers found that eyes with UG more frequently require additional cataract surgery after trabeculectomy. Prognostic factors for the failure of trabeculectomy in eyes with UG include previous cataract surgery and granulomatous uveitis.

For this retrospective, consecutive, comparative cohort study, researchers at two Japanese clinical centres included 204 patients who underwent trabeculectomy with MMC between 1999 and 2008. Included were 101 eyes with UG and 103 eyes with primary open-angle glaucoma (POAG). Surgical failure was defined as IOPs of ≥ 21 mmHg or the requirement of an additional glaucoma procedure.

Kaplan-Meier survival curves for surgical failure were used to compare results from the two groups, and as was Cox proportional hazards modeling to determine the prognostic factors for surgical failure of trabeculectomy in UG eyes. Secondary outcomes included comparisons of the frequency of additional cataract surgery and other surgical complications after trabeculectomy between UG and PAGE eye.

Mean follow-up in the UG and POAG groups were 34.7 and 37.7 months. Subtypes of uveitis identified included granulomatous uveitis (n = 20) including sarcoidosis (n = 12), Vogt-Koyanagi-Harada disease (n = 5), and varicella zoster virus uveitis (n =3), Behçet’s disease (n = 10), Posner-Schlossman syndrome (n = 5), and other types of UG (n = 12). In addition, 54 eyes were diagnosed with idiopathic UG.

The 3-year probabilities of success after trabeculectomy were 71.3% in the UG group, and 89.7% in the POAG group (P = 0.0171). Multivariate modeling showed that UG eyes with previous cataract surgery (P = 0.0344) and granulomatous uveitis (P = 0.0106) were associated with surgical failure. UG eyes had more frequent cataract surgeries after trabeculectomy compared with POAG eyes, with the 3-year probability of additional cataract surgery of 62.6% in UG and 10.7% in POAG eyes (P

For more information on this study, please click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.